News Snapshot:
: Saturday, August 22, 2020, 10:52 PM IST Chinese inactivated COVID-19 vaccine starts phase-3 clinical trials in Argentina By Xinhua Representational Image An inactivated COVID-19 vaccine developed by China has started phase-3 clinical trials in Argentina, according to its developer China National Biotec Group (CNBG), which is affiliated to Sinopharm. The launch ceremony of the phase-3 clinical trials was held in Beijing Friday after the CNBG obtained the certificate of approval for the process. This is an achievement brought about by CNBG's international cooperation in a bid to develop a COVID-19 vaccine. The inactivated vaccine received approval for phase-3 clinical...
